Production of Synthetic Adjuvant System (SAS)

NIH RePORTER · NIH · N44 · $1,992,471 · view on reporter.nih.gov ↗

Abstract

The company will develop a synthetic adjuvant system (SAS) containing a TLR-4 agonist combined with a saponin-based adjuvant, in which both components synergize to elicit a Th1-biased immune response.

Key facts

NIH application ID: 10244740
Project number: 75N93020C00021-0-9999-1
Recipient: INIMMUNE CORPORATION
Principal Investigator: SHANNON MILLER
Activity code: N44
Funding institute: NIH
Fiscal year: 2020
Award amount: $1,992,471
Award type: —
Project period: 2020-06-01 → 2022-05-31